Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengqiao Li

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
CNS & Neurological Disorders Drug Targets|December 18, 2009
Novel anti-inflammatory and neuroprotective agents for Parkinson's diseaseLi Lu, Fengqiao Li, Xiaomin Wang
Methods in Molecular Biology (Clifton, N.J.)|September 30, 2021
Injectable Hydrogels for Vascular Tissue EngineeringFengqiao Li, William Ho, Xiaoyang Xu
Eco-Environment & Health|December 11, 2023
Microbiome sustains forest ecosystem functions across hierarchical scalesFengqiao Li, Haiyun Zi, Christian Sonne, et al.
Msystems|August 9, 2022
Host Plant Selection Imprints Structure and Assembly of Fungal Community along the Soil-Root ContinuumFengqiao Li, Zhili Jin, Zichen Wang, et al.
Advanced Healthcare Materials|January 18, 2021
Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA DeliveryWilliam Ho, Mingzhu Gao, Fengqiao Li, et al.
ACS Nano|July 25, 2023
Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate CellsChenshuang Zhang, Yilong Teng, Fengqiao Li, et al.
ACS Nano|October 21, 2022
Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 VaccinesZhongyu Li, Xue-Qing Zhang, William Ho, et al.
Nature Communications|July 15, 2023
mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapyFengqiao Li, Xue-Qing Zhang, William Ho, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 21, 2020
Nanoparticle depots for controlled and sustained gene deliveryZhongyu Li, William Ho, Xin Bai, et al.
Current Cancer Drug Targets|June 30, 2018
Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug DeliveryXiaodong Xie, Yingying Zhang, Fengqiao Li, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
CNS & Neurological Disorders Drug Targets|December 18, 2009
Novel anti-inflammatory and neuroprotective agents for Parkinson's diseaseLi Lu, Fengqiao Li, Xiaomin Wang
Methods in Molecular Biology (Clifton, N.J.)|September 30, 2021
Injectable Hydrogels for Vascular Tissue EngineeringFengqiao Li, William Ho, Xiaoyang Xu
Eco-Environment & Health|December 11, 2023
Microbiome sustains forest ecosystem functions across hierarchical scalesFengqiao Li, Haiyun Zi, Christian Sonne, et al.
Msystems|August 9, 2022
Host Plant Selection Imprints Structure and Assembly of Fungal Community along the Soil-Root ContinuumFengqiao Li, Zhili Jin, Zichen Wang, et al.
Advanced Healthcare Materials|January 18, 2021
Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA DeliveryWilliam Ho, Mingzhu Gao, Fengqiao Li, et al.
ACS Nano|July 25, 2023
Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate CellsChenshuang Zhang, Yilong Teng, Fengqiao Li, et al.
ACS Nano|October 21, 2022
Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 VaccinesZhongyu Li, Xue-Qing Zhang, William Ho, et al.
Nature Communications|July 15, 2023
mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapyFengqiao Li, Xue-Qing Zhang, William Ho, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 21, 2020
Nanoparticle depots for controlled and sustained gene deliveryZhongyu Li, William Ho, Xin Bai, et al.
Current Cancer Drug Targets|June 30, 2018
Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug DeliveryXiaodong Xie, Yingying Zhang, Fengqiao Li, et al.
Pageof 4